Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
04/30/2008 | CN101171250A Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
04/30/2008 | CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
04/30/2008 | CN101171246A Stable micronized candesartan cilexetil and methods for preparing thereof |
04/30/2008 | CN101171244A Indazolylamino quinazoline derivatives as antitumor agents |
04/30/2008 | CN101171076A Affinity adsorbents for factor viii and von willebrand's factor |
04/30/2008 | CN100384840C 2-pyrimidine oxy-benzoic acid [2-(pyrimidine amino methyl)]benester compound, its preparation and use thereof |
04/30/2008 | CN100384835C Compound of biindole heterocycles, preparation method and application in use for organic electroluminescence material |
04/30/2008 | CN100384825C Benzheterocyclic derivatives |
04/30/2008 | CN100384424C Synergistic methods and compositions for treating cancer |
04/30/2008 | CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
04/29/2008 | US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
04/29/2008 | US7365199 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
04/29/2008 | US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
04/29/2008 | US7365090 Substituted phenylindoles for the treatment of HIV |
04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
04/29/2008 | US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
04/29/2008 | US7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
04/29/2008 | US7364656 Triazine-based detoxification agents and their use |
04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
04/29/2008 | CA2245484C Novel urea derivatives |
04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
04/28/2008 | CA2666880A1 Organic compounds |
04/24/2008 | WO2008049123A2 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
04/24/2008 | WO2008049116A2 Substituted indoles |
04/24/2008 | WO2008049027A1 Talarazole metabolites |
04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
04/24/2008 | WO2008047831A1 Jak inhibitor |
04/24/2008 | WO2008046756A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
04/24/2008 | WO2008046657A1 Triazines and their use as inhibitors of metalloproteinases |
04/24/2008 | WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases |
04/24/2008 | WO2008046216A1 Kinase inhibitors and uses thereof |
04/24/2008 | WO2008020227A3 Antibacterial pyrrolecarboxamides |
04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
04/24/2008 | WO2008005519A3 Novel pyridazine compound and use thereof |
04/24/2008 | WO2007106192A3 Inhibitors of iap |
04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
04/24/2008 | US20080096955 Histamine-3 receptor antagonists |
04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
04/24/2008 | US20080096945 Amorphous and Crystalline Forms of Losartan Potassium and Process For Their Preparation |
04/24/2008 | US20080096944 Preparing aqueous sodium irbesartan and displacing the sodium with magnesium or calcium ions; solvent-free; easily sterilized aqueous solutions; controlled crystallization, easy filtration and drying; nonelectrostatic behavior and ready tabletting |
04/24/2008 | US20080096912 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
04/24/2008 | US20080096906 good affinity to the trace amine associated receptors (TAARs), especially for TAAR1; (3-Chloro-phenyl)-(1H-imidazol-2-ylmethyl)-methyl-amine from 3-chloro-N-methylaniline and imidazole-2-carboxyaldehyde and reduction of the carbonyl to methylene |
04/24/2008 | US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases |
04/24/2008 | US20080096899 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof |
04/24/2008 | US20080096897 water soluble; lower toxicity by photosensitization; anticancer; antitumor; antiinflammatory; arthritis; osteoporosis; ocular abnormal angiogenesis; multiple sclerosis, asthma, atherosclerosis |
04/24/2008 | US20080096895 Heterocyclic Derivatives and Their Use as Stearoyl-Coa Desaturase Inhibitors |
04/24/2008 | US20080096892 C-Kit Modulators And Methods Of Use |
04/24/2008 | US20080096888 Novel compounds as opioid receptor modulators |
04/24/2008 | US20080096886 amidation of 3-(benzyloxy)-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid via the 2-acid chloride and then reaction with an amine; hydrolysis or catalytic hydrogenation to deprotect 3-hydroxy group; high yields for industrial application; the 3-(benzyloxy)-2-carboxamide intermediate |
04/24/2008 | US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors |
04/24/2008 | US20080096877 Glucokinase activators; prophylaxis or treatment of diabetes, obesity; sulfonamide or sulfonate-functional thiazole or thiadiazole-substituted indoles; N,N-dimethyl-2-{4-[(2-{7-[methyl(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetamide for example |
04/24/2008 | US20080096864 Partially imatinib-resistant tumors; synergistic; combined packaging; oral administration |
04/24/2008 | US20080096860 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
04/24/2008 | US20080096220 Novel triazine-based detoxification agents and their use |
04/24/2008 | DE102006048924A1 Acylaminopyrazole Acylaminopyrazole |
04/24/2008 | CA2673125A1 Compositions and methods for inhibition of the jak pathway |
04/24/2008 | CA2667053A1 Talarazole metabolites |
04/24/2008 | CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases |
04/24/2008 | CA2666149A1 Substituted indoles |
04/24/2008 | CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
04/23/2008 | EP1913015A1 Macrocyclic inhibitors of hepatitis c virus |
04/23/2008 | EP1912998A1 Pyrazole derivatives having tyrosinkinase activity |
04/23/2008 | EP1912976A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
04/23/2008 | EP1912975A1 A process for the preparation of telmisartan |
04/23/2008 | EP1912974A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
04/23/2008 | EP1912966A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
04/23/2008 | EP1912940A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
04/23/2008 | EP1912939A1 Metabotropic glutamate-receptor-potentiating isoindolones |
04/23/2008 | EP1912706A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
04/23/2008 | EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones |
04/23/2008 | EP1333834B1 Antiinflammation agents |
04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
04/23/2008 | CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
04/23/2008 | CN101166729A Fused heterocyclic compounds |
04/23/2008 | CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
04/23/2008 | CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators |
04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
04/23/2008 | CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
04/23/2008 | CN101166721A 1-acetic acid-indole derivatives with pgd2 antagonist activity |
04/23/2008 | CN101166529A Benzotriazole derivatives as cannabinoid receptor antagonists |
04/23/2008 | CN101165062A Novel synthesis of irbesartan |
04/23/2008 | CN101165057A Nbeta-substituted phenyluracil compounds for removing glass |
04/23/2008 | CN101165050A Benzoisoindole derivative, pigment composition comprising the same and colored composition |
04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
04/22/2008 | US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
04/22/2008 | US7361719 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
04/22/2008 | US7361682 Indole derivatives as H3 inverse agonists |
04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |